|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| asco@alo33 |
161904 |
Background: Personalized therapy in lung cancer has improved folloing the introduction of EGFR tyrosine kinase inhibitors. Hoever, virtually all patients develop resistance leading to disease relaps |
2.24 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161922 |
Background: Primary breast sarcoma PBS is an extremely rare and heterogeneous group of malignancies ith limited publications confined to small retrospective case revies and case reports. Optimal c |
2.18 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161925 |
Background: Human Papilloma Virus HPV related oropharyngeal squamous cell cancer OPSCC is distinct from that attributable to tobacco use, ith better prognosis and treatment response. While HPV s |
2.17 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161930 |
Background: Access to COG clinical trials has led to significant improvements in overall survival rates; hoever, disparities persist, particularly among Black and Hispanic patients, AYAs, and the in |
2.2 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161931 |
Background: Both efficacy and toxicity impact a persons experience ith chemotherapy, as recognized in a recently published ASCO frameork. A number of approved chemotherapy agents require early dose |
2.05 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161940 |
Background: Fatigue is a distressing side effect of cancer therapy. Emerging evidence suggests immunological involvement in the pathogenesis of chronic fatigue CF related to radiation therapy RT |
2 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161948 |
Background:x3A4;o evaluate the predictive value of genes involved in resistance to platinum-taxane chemotherapy in patients ith epithelial ovarian cancer EOC . Material and Methods: Microdissected |
1.68 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161961 |
Background: Standard antiemetic therapy for chemotherapy-induced nausea and vomiting in high emetogenic chemotherapy HEC is a combination of NK1 receptor antagonist, 5-HT3 receptor antagonist and |
2.42 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161963 |
Background: Pancreatic cancer PC is one of the most deadly cancers. Existing tumor markers, such as carbohydrate antigen 19-9 and carcinoembryonic antigen, have relatively poor diagnostic sensitiv |
1.67 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161970 |
Background: Considering the high prevalence of comorbidities in multiple myeloma MM patients, comorbidity has an important issue for the management of myeloma. Hoever, the impact of comorbidity on |
1.99 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
